(Q34354479)

1 August 2017

title

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene (English)

1 reference

1 August 2017

1 reference

2

Zsofia Kote-Jarai

1 reference

1 August 2017

Richard Oram

17

0 references

Rosalind Eeles

object named as

Rosalind A Eeles

23

0 references

Simon A Gayther

21

object named as

Simon A Gayther

1 reference

1 August 2017

22

Doug F Easton

1 reference

1 August 2017

Stephen M Edwards

1

1 reference

1 August 2017

Julia Meitz

3

1 reference

1 August 2017

Rifat Hamoudi

4

1 reference

1 August 2017

Questa Hope

5

1 reference

1 August 2017

Peter Osin

6

1 reference

1 August 2017

Rachel Jackson

7

1 reference

1 August 2017

Christine Southgate

8

1 reference

1 August 2017

Rashmi Singh

9

1 reference

1 August 2017

Alison Falconer

10

1 reference

1 August 2017

David P Dearnaley

11

1 reference

1 August 2017

Audrey Ardern-Jones

12

1 reference

1 August 2017

Annette Murkin

13

1 reference

1 August 2017

Anna Dowe

14

1 reference

1 August 2017

Jo Kelly

15

1 reference

1 August 2017

Sue Williams

16

1 reference

1 August 2017

Margaret Stevens

18

1 reference

1 August 2017

Dawn M Teare

19

1 reference

1 August 2017

Bruce A J Ponder

20

1 reference

1 August 2017

Cancer Research UK/Bristish Prostate Group UK Familial Prostate Cancer Study Collaborators

24

1 reference

1 August 2017

British Association of Urological Surgeons Section of Oncology

25

1 reference

1 August 2017

language of work or name

English

0 references

publication date

9 December 2002

1 reference

American Journal of Human Genetics

1 August 2017

published in

1 reference

1 August 2017

volume

72

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

1-12

1 reference

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

A candidate prostate cancer susceptibility gene at chromosome 17p

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Cancer risks in BRCA2 mutation carriers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

BRCA2 mutation in Icelandic prostate cancer patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Transcriptional activation functions in BRCA2

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

The BRC repeats are conserved in mammalian BRCA2 proteins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Allelic loss on chromosome 13q in human prostate carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Allelic loss and microsatellite instability in prostate cancers in Japan.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

An improved high throughput heteroduplex mutation detection system for screeningBRCA2 mutations?fluorescent mutation detection (F-MD)

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Evidence for a prostate cancer susceptibility locus on the X chromosome.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=420008

Distinct regions of allelic loss on 13q in prostate cancer

9 December 2018

1 reference

12 December 2020

Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations

1 reference

12 December 2020

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1086/345310

1 reference

1 August 2017

1 reference

1 August 2017

1 reference